180 related articles for article (PubMed ID: 19751436)
1. Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients.
Wang X; Yang J; Ho B; Yang Y; Huang Z; Zhang Z; Zhang G
Helicobacter; 2009 Oct; 14(5):114-9. PubMed ID: 19751436
[TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.
Pan X; Li Y; Feng J; Wang X; Hao B; Shi R; Zhang G
BMC Cancer; 2013 Mar; 13():126. PubMed ID: 23506213
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection and MDM2 SNP309 association with gastric cancer susceptibility.
Moradi MT; Salehi Z; Asl SF; Aminian K; Hashtchin AR
Genet Test Mol Biomarkers; 2013 Nov; 17(11):794-8. PubMed ID: 24010568
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphism of MDM2 SNP309 in Patients with Helicobacter Pylori-Associated Gastritis.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(16):7049-52. PubMed ID: 26514489
[TBL] [Abstract][Full Text] [Related]
5. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
6. Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand.
Tongtawee T; Simawaranon T; Wattanawongdon W
Turk J Gastroenterol; 2018 Sep; 29(5):555-560. PubMed ID: 30260777
[TBL] [Abstract][Full Text] [Related]
7. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
Ma Y; Bian J; Cao H
PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
[TBL] [Abstract][Full Text] [Related]
8. A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.
Nan H; Qureshi AA; Hunter DJ; Han J
Cancer Causes Control; 2009 Mar; 20(2):171-9. PubMed ID: 18814047
[TBL] [Abstract][Full Text] [Related]
9. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
Ohmiya N; Taguchi A; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
J Clin Oncol; 2006 Sep; 24(27):4434-40. PubMed ID: 16983111
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
[TBL] [Abstract][Full Text] [Related]
11. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
[TBL] [Abstract][Full Text] [Related]
12. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
[TBL] [Abstract][Full Text] [Related]
13. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
Wan Y; Wu W; Yin Z; Guan P; Zhou B
BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population.
Ma H; Hu Z; Zhai X; Wang S; Wang X; Qin J; Jin G; Liu J; Wang X; Wei Q; Shen H
Cancer Lett; 2006 Aug; 240(2):261-7. PubMed ID: 16288830
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population.
Hu Z; Ma H; Lu D; Qian J; Zhou J; Chen Y; Xu L; Wang X; Wei Q; Shen H
Int J Cancer; 2006 Mar; 118(5):1275-8. PubMed ID: 16152608
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population.
Zhang X; Zheng L; Sun Y; Zhang X
Tumour Biol; 2014 Feb; 35(2):1575-80. PubMed ID: 24218334
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.
Xiao FK; Guo S; Yang F; Zhao LS; Wang LD
J Gene Med; 2019 May; 21(5):e3086. PubMed ID: 30861607
[TBL] [Abstract][Full Text] [Related]
18. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.
Zhou G; Zhai Y; Cui Y; Zhang X; Dong X; Yang H; He Y; Yao K; Zhang H; Zhi L; Yuan X; Qiu W; Zhang X; Shen Y; Qiang B; He F
Clin Cancer Res; 2007 May; 13(9):2627-33. PubMed ID: 17473193
[TBL] [Abstract][Full Text] [Related]
19. Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population.
Moradi MT; Salehi Z; Aminian K; Yazdanbod A
Asian Pac J Cancer Prev; 2014; 15(17):7413-7. PubMed ID: 25227851
[TBL] [Abstract][Full Text] [Related]
20. Role of the Mdm2 SNIP 309 Polymorphism in Gastric Mucosal Morphologic Patterns of Patients with Helicobacter pylori Associated Gastritis.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2016; 17(3):1057-60. PubMed ID: 27039725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
